Background: Myasthenia gravis (MG) is an autoimmune disease affecting patients' quality of life and necessitating long-term medical therapy. The efficacy of thymectomy for treatment of MG has been well established. Although several techniques have been used for thymectomy, there has been controversy over the best method with highest rate of improvement. Herein, we discuss our seven years of clinical experience with thoracoscopic thymectomy for MG.
INTRODUCTION
Myasthenia gravis is an autoimmune neuromuscular transmission disorder, which can affect patients' quality of life if left untreated (1, 2) . It is not an uncommon disease with an incidence of 30 per one million per year (3) . This disorder is characterized by progressive weakness and fatigue of voluntary skeletal muscles and most patients present with ptosis and diplopia (2) . It is believed that thymus gland has an important role in the pathogenesis of MG by T-lymphocyte education and self-tolerance (2, 3) and therefore in addition to medical therapy, thymectomy has been accepted as a therapeutic option by both surgeons and neurologists (4) (5) (6) (7) (8) . Although different techniques for thymectomy have been explained, the ideal approach still remains controversial. In this study, we present the results
of thoracoscopic thymectomy in Masih Daneshvari
Hospital, Tehran, Iran. All patients underwent thoracoscopic thymectomy.
MATERIALS AND METHODS

Clinical
Although operations were performed by different surgeons, same dissections were done as a rule in our department.
All patients were followed up for at least 3 years.
Postoperative visits were done in distinct intervals and also depending on patients' status. Patients were evaluated for symptoms, medications used, alterations of medications and also satisfaction with the operation.
We defined the results of our operations as: complete remission when there was no muscle weakness and no In our study, 22 patients were operated earlier than one year and 12 patients were operated 12 to 42 months after the diagnosis. In the first group, cumulative remission was seen in 20 patients (90.9%) and in the second group it was achieved in only 9 patients (75%). Unresponsive rate was 4.5% and 16.7%, respectively and deterioration was seen in one patient in both groups (Table 2) . Although there was no statistically significant difference (P=0.065) in improvement rates between the two groups, it was also shown in our study that thymectomy soon after the diagnosis may result in higher improvement rate. It is also believed that thymectomy early after the diagnosis of MG would be associated with a higher rate of improvement and remission and so it is recommended to perform thymectomy early after the diagnosis is made regardless of age, stage, thymic pathology and preoperative clinical status (23, 24) .
CONCLUSION
According to our results and compared to other reports in the literature, we believe that thoracoscopic thymectomy is a safe procedure with acceptable rates of remission in patients with MG and may be associated with higher rates of improvement if performed early after the diagnosis.
